Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising gene-corrected primary cells

Pharmaceutical compositions comprising gene-corrected primary cells

US Patent 11634732 · Granted Apr 25, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Scarless genome editing through two-step homology directed repair2025
Materials and methods for treatment of hemoglobinopathies2024
Materials and methods for treatment of human genetic diseases including hemoglob2024
Materials and methods for treatment of hemoglobinopathies2024
Genome editing of graft-derived T-cells for post-transplant immunotherapy2024
Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated e2023
Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated e2023
Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated e2023
CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous re2023
CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous re2023
Scarless genome editing through two-step homology directed repair2023
Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation2022